FourThought Financial Partners LLC Reduces Stock Position in Sanofi (NASDAQ:SNY)

FourThought Financial Partners LLC lessened its holdings in Sanofi (NASDAQ:SNY) by 6.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,130 shares of the company’s stock after selling 461 shares during the quarter. FourThought Financial Partners LLC’s holdings in Sanofi were worth $344,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of SNY. Synergy Asset Management LLC purchased a new position in Sanofi in the fourth quarter valued at $25,000. McClarren Financial Advisors Inc. boosted its stake in shares of Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after buying an additional 543 shares during the period. Concord Wealth Partners boosted its stake in shares of Sanofi by 157.8% during the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after buying an additional 363 shares during the period. Fortitude Family Office LLC boosted its stake in shares of Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after buying an additional 659 shares during the period. Finally, Sunbelt Securities Inc. boosted its stake in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after buying an additional 313 shares during the period. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Sanofi Stock Up 2.1 %

SNY stock opened at $54.89 on Wednesday. The stock has a market capitalization of $139.30 billion, a P/E ratio of 22.04, a PEG ratio of 1.01 and a beta of 0.57. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. Sanofi has a one year low of $45.22 and a one year high of $58.97. The company has a 50 day moving average price of $51.22 and a two-hundred day moving average price of $52.56.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. As a group, sell-side analysts expect that Sanofi will post 4.36 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Finally, Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.